Pesquisar
Cryo-Cell International Inc
CCELAdicionar à lista de desejos
3.220USD
+0.030+0.94%
Fechamento 07/01, 16:00（ET）Cotações atrasadas em 15 min
25.94MValor de mercado
PerdaP/L TTM
Mais detalhes de Cryo-Cell International Inc Empresa
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Informações de Cryo-Cell International Inc
Código da empresaCCEL
Nome da EmpresaCryo-Cell International Inc
Data de listagemApr 04, 1994
CEOPortnoy (Mark L)
Número de funcionários82
Tipo de títulosOrdinary Share
Fim do ano fiscalApr 04
Endereço700 Brooker Creek Blvd
CidadeOLDSMAR
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal34677
Telefone18137492104
Sitehttps://www.cryo-cell.com/
Código da empresaCCEL
Data de listagemApr 04, 1994
CEOPortnoy (Mark L)
Executivos da empresa Cryo-Cell International Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.70M
+0.92%
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
--
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
52.90K
+14.18%
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Cryo-Cell International Inc?
Os cinco principais acionistas de Cryo-Cell International Inc são: Mr. David I. Portnoy
Quantas instituições possuem ações da Cryo-Cell International Inc (CCEL)?
Em 2026Q1, 36 instituições possuíam ações da Cryo-Cell International Inc, com valor de mercado aproximado de 1.00M, representando 12.47% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -82390.00.
Qual é a maior fonte de receita da Cryo-Cell International Inc?
Em 2026Q1, o segmento de negócios Processing and storage fees gerou a maior receita para Cryo-Cell International Inc, totalizando 31.38M e representando 99.42% da receita total.